European Journal of Health Economics

Papers
(The H4-Index of European Journal of Health Economics is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Public health policies for the common interest: rethinking EU states’ incentives strategies when a pandemic reshuffles all interests138
Informal care at old age at home and in nursing homes: determinants and economic value96
The effect of telephone health coaching and remote exercise monitoring for peripheral artery disease (TeGeCoach) on health care cost and utilization: results of a randomized controlled trial58
Scales and size-quality outcomes in adult learning disability residential care: evidence from the UK55
Comparing the measurement properties of the ICECAP-A and ICECAP-O instruments in ages 50–70: a cross-sectional study on a representative sample of the Hungarian general population48
Costing methodologies in European economic evaluation guidelines: commonalities and divergences45
Obesity epidemic in European countries: from an unaddressed risk factor to a medicalized disease?43
Cost-effectiveness analysis of (accelerated) pre-operative versus (conventional) post-operative radiotherapy for patients with oral cavity cancer in Sweden41
Insurance coverage, long-term care utilization, and health outcomes36
The role of health at birth and parental investment in early child development: evidence from the French ELFE cohort31
Home sweet home: GPs’ response to an increase in the fee size for home visits28
Obesity and labour market outcomes in Italy: a dynamic panel data evidence with correlated random effects26
Alcohol prices, the April effect, and the environment, in violence-related injury in England and Wales25
Education and medication use later in life and the role of intelligence22
Health impact of borders: general reflections and a case study from the Polish–German border22
Characteristics and health care costs in patients with a diagnostic imaging for low back pain in Switzerland21
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries21
Psychometric properties and general population reference values for PROMIS Global Health in Hungary21
A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerl21
A systematic review of the cost-effectiveness of interventions to increase cervical cancer screening among underserved women in Europe21
The hidden cost of sophistication: economic complexity and obesity20
Measuring the acceptability of EQ-5D-3L health states for different ages: a new adaptive survey methodology20
0.093023061752319